Brief: BioArctic's Leqembi Approved For Treatment Of Alzheimer's In Israel
12/07/2024 06:24
July 12 (Reuters) - BioArctic AB BIOAb.ST :
* LEQEMBI APPROVED FOR THE TREATMENT OF ALZHEIMER'S DISEASE
IN
ISRAEL
Source text for Eikon: ID:nPnbyMpSVa
Further company coverage: BIOAb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on BioArctic AB (publ)
See all newsBrief: BioArctic Gets Leqembi Pen Subcutaneous Formulation Approval In Japan
Brief: BioArctic Says Leqembi Subcutaneous Formulation Approved For Initiation Treatment In China
Brief: BioArctic Says Canada's Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement Of Leqembi
Sweden's BioArctic Q2 revenue falls despite higher Leqembi royalties
Brief: BioArctic Q2 Net Sales Down At SEK 247.5 Mln